OpenBilldrug price receipt

NADAC week of 2026-10-14

CYCLOBENZAPRINE ER 15 MG CAP

For 30 capsules

Pharmacies pay

$35.57 filed

30 × $1.18556 per EA

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

Medicare

We don’t know yet

No Medicare reference price. Part D: The Part D file flags this drug’s average spending per dosage unit as an outlier, so OpenBill does not use it as a reference price. Part B: This NDC is not in the current quarter’s Medicare Part B NDC-HCPCS crosswalk, so it has no Part B payment limit.


The spread

We don’t know yet

There is no Medicare figure to compare with, so there is no spread.

Cost-plus estimate

$45.91 estimated

$35.57 + $5.34 (15%) + $5.00 fee per fill = $45.91

This is a model, not a price any pharmacy quoted. Shipping is not included. How it is worked out

OpenBill calculation · nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17)

Open the interactive card Change the quantity, type what you were charged, and see every record in full.

What it is

CYCLOBENZAPRINE ER 15 MG CAP is how the CMS NADAC file names this product. The FDA NDC Directory lists it as cyclobenzaprine hydrochloride.

FDA gives its dosage form as capsule, extended release and its route as oral.

Its labelers, the companies named on the label, are Teva Pharmaceuticals USA, Inc., Amneal Pharmaceuticals of New York LLC and Upsher-Smith Laboratories, LLC.

FDA’s Established Pharmacologic Class for it is Muscle Relaxant.

The NADAC file of 2026-10-14 prices it under 3 NDCs (National Drug Codes).

NADAC classes it as a generic drug (rate-setting class G), and does not mark it as sold over the counter.

What pharmacies pay

Pharmacies pay $35.57 for 30 capsules (30 × $1.18556 per EA, rounded to the cent), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-09-23. That is what pharmacies pay their suppliers, not what they charge you.

NADAC’s explanation codes for it: 1, calculated from the most recently completed pharmacy survey; 6, the CMS Covered Outpatient Drug Product File S/I/N drug category was not applied when grouping drugs for the calculation.

All 3 NDCs

Other strengths, forms and brands

8 other products in the NADAC file share the FDA nonproprietary name cyclobenzaprine hydrochloride with CYCLOBENZAPRINE ER 15 MG CAP.

ProductPharmacies pay per unitMedicare per unit
AMRIX ER 15 MG CAPSULE
brand · capsule, extended release
$66.23256 per EA filed
eff. 2026-01-01
We don’t know yet
AMRIX ER 30 MG CAPSULE
brand · capsule, extended release
$66.56709 per EA filed
eff. 2026-01-01
We don’t know yet
CYCLOBENZAPRINE 5 MG TABLET
generic · tablet, film coated / tablet
$0.02197 per EA filed
eff. 2026-09-23
$0.14207 per EA filed
Part D 2024 average
CYCLOBENZAPRINE 7.5 MG TABLET
generic · tablet, film coated
$0.26288 per EA filed
eff. 2026-09-23
$0.14207 per EA filed
Part D 2024 average
CYCLOBENZAPRINE 10 MG TABLET
generic · tablet, film coated / tablet
$0.01712 per EA filed
eff. 2026-09-23
$0.14207 per EA filed
Part D 2024 average
CYCLOBENZAPRINE ER 15 MG CAP this page
generic · capsule, extended release
$1.18556 per EA filed
eff. 2026-09-23
We don’t know yet
CYCLOBENZAPRINE ER 30 MG CAP
generic · capsule, extended release
$1.0822 per EA filed
eff. 2026-09-23
We don’t know yet
FEXMID 7.5 MG TABLET
generic · tablet
$0.26288 per EA filed
eff. 2026-09-23
$0.14207 per EA filed
Part D 2024 average
TONMYA 2.8 MG TABLET SL
brand · tablet, orally disintegrating
$29.60952 per EA filed
eff. 2026-09-23
We don’t know yet

Part D is one average per brand and generic name, over every strength and form.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-01-01, 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18

Compared with its class

The middle of its 3 NDCs’ NADAC prices is $1.18556 per EA filed.

Of the 22 other products in FDA’s Muscle Relaxant class priced per EA, 8 have a higher middle NADAC price and 14 a lower one. The one in the middle is CARISOPRODOL 250 MG TABLET, at $0.47389 per EA filed (eff. 2026-09-23).

Prices are compared per unit, whatever the strength or dose, and a class is not a list of substitutes.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

What Medicare paid

We don’t know yet; the card above says why.

What to ask at the counter

None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.